BSNDP4

Across TCGA pan-cancer cohorts, BSNDP4 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated BSNDP4 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher BSNDP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BSNDP4 expression acts as an unfavorable survival marker, although some lineages such as TGCT show a favorable association.

LIHC, UCS, and COAD are the cancer types where BSNDP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.283	0.694	<.001	114	view →
UCS	OS	Tertile	II,III,IV	0.116	0.629	<.001	108	view →
COAD	OS	Tertile	All	0.163	0.870	<.001	54	view →
THYM	DFS	Tertile	All	0.091	0.884	<.001	36	view →
LUAD	OS	Tertile	III,IV	0.223	0.663	.034	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	12	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
LUSC	DFS	Tertile	II,III,IV	0.234	0.404	.030	6	view →
TGCT	DFS	Quartile	All	0.985	0.798	.023	2	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

BSNDP4–LIHC (OS)

Open the LIHC breakdown →